Results 251 to 260 of about 6,506,838 (308)

Correction: Feemster et al. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. <i>Vaccines</i> 2024, <i>12</i>, 974. [PDF]

open access: yesVaccines (Basel)
Feemster K   +8 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Cross protection among four viroids

Virology, 1978
Abstract Cross-protection tests were performed on tomato and/or chrysanthemum plants with a severe strain (PS) of potato spindle tuber viroid (PSTV), a mild strain of PSTV (PM), citrus exocortis viroid (CEV), chrysanthemum stunt viroid (CSV), and chrysanthemum chlorotic mottle viroid (ChCMV).
C L, Niblett   +4 more
openaire   +2 more sources

Mechanisms of cross-protection.

CABI Reviews, 2008
Abstract Cross-protection is a phenomenon in which mild or attenuated strains of a virus protect plants against secondary infections with a more severe strain of the same virus. Though this phenomenon was described in the 1920s, the mechanism(s) behind it have been poorly understood for many years.
openaire   +1 more source

On the need for, and the delivery of, cross-protective vaccines

Vaccine, 2005
The rhinoviruses that are instrumental in causing about one-third of the outbreaks of the common cold present us with some 100 or so serotypes whose convalescent sera do not cross-neutralise. A similar situation prevails with the organism that causes gonorrhoea. Both the HIV and the protozoan causing malaria are notorious for their ability to evade the
openaire   +2 more sources

Strategies for Viral Cross Protection in Plants

2012
Viral cross protection in plants is known as an acquired immunity phenomenon, where a mild virus isolate/strain can protect plants against economic damage caused by a severe challenge strain/isolate of the same virus. Mild strain cross protection (MSCP) has been used extensively to control losses caused by a few major virus diseases in some parts of ...
Changyong, Zhou, Yan, Zhou
openaire   +2 more sources

Home - About - Disclaimer - Privacy